Predictive Oncology Faces Delisting Concerns
Ticker: AGPU · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1446159
Sentiment: bearish
Topics: delisting, compliance, listing-standards
TL;DR
Predictive Oncology Inc. is on notice for potential delisting from the stock exchange.
AI Summary
Predictive Oncology Inc. filed an 8-K on July 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The specific reason for this notice, which relates to the company's listing status, is detailed within the filing.
Why It Matters
This filing indicates potential issues with Predictive Oncology Inc.'s compliance with stock exchange listing requirements, which could impact its stock's tradability and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on an exchange.
Key Players & Entities
- Predictive Oncology Inc. (company) — Registrant
- July 8, 2025 (date) — Earliest event reported
- July 11, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific listing rule or standard has Predictive Oncology Inc. failed to satisfy?
The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard within the provided text.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 8, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on July 11, 2025.
What is the company's state of incorporation?
Predictive Oncology Inc. is incorporated in Delaware.
What is the company's Commission File Number?
The company's Commission File Number is 001-36790.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding Predictive Oncology Inc. (AGPU).